Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Globofarm International is an Austrian pharmaceutical company specializing in the development, licensing, and supply of high-quality generic and value-added medicinal products. The company operates primarily as a B2B partner, providing pharmaceutical dossiers in EU-CTD format and finished dosage forms to global partners for local marketing and distribution. Their portfolio covers a wide range of therapeutic areas, with a strategic focus on niche products and complex formulations that require specialized development expertise. Globofarm manages the entire product lifecycle, from initial formulation and clinical bioequivalence studies to regulatory submission and long-term commercial supply from EU-GMP certified facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Globofarm International.